Solara Active Pharma names Bharath R Sesha as new CEO

Published On 2019-12-09 09:45 GMT   |   Update On 2019-12-09 09:45 GMT

"The Board of Directors, on the recommendation of Nomination and Remuneration Committee, have appointed Bharath R Sesha as Chief Executive Officer of the Company with effect from December 09, 2019," Solara Active Pharma Sciences said in a regulatory filing.


New Delhi: Solara Active Pharma Sciences on Monday said it has appointed Bharath R Sesha as its Chief Executive Officer (CEO) with immediate effect.


"The Board of Directors, on the recommendation of Nomination and Remuneration Committee, have appointed Bharath R Sesha as Chief Executive Officer of the Company with effect from December 09, 2019," the company said in a regulatory filing.


As part of an agreed succession plan, Sesha will succeed Jitesh Devendra as Solara's new CEO.


Also Read: Biocon names Siddharth Mittal as new CEO, Joint MD; bids farewell to Arun Chandavarkar


Sesha has over two decades of experience and joined Solara from Nalco Water, India where he was the Managing Director responsible for the growth strategy.


"These are exciting times for the industry, and I hope we will continue to create new opportunities for growth in our business to drive significant value for all the stakeholders," Sesha said.


Bengaluru-based Solara Active Pharma Sciences has a manufacturing base comprising five globally compliant active pharmaceutical ingredient (API) facilities, with approvals including the USFDA, European good manufacturing practice (EU GMP) and Pharmaceutical and Medical Devices Agency (PMDA) in Japan.


Also Read: Everstone-backed Everlife names Raman Gandotra as new CEO

Article Source : PTI

Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News